BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36978829)

  • 1. Progranulin Deficiency Induces Mitochondrial Dysfunction in Frontotemporal Lobar Degeneration with TDP-43 Inclusions.
    Rodríguez-Periñán G; de la Encarnación A; Moreno F; López de Munain A; Martínez A; Martín-Requero Á; Alquézar C; Bartolomé F
    Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing progranulin levels and blockade of the ERK1/2 pathway: upstream and downstream strategies for the treatment of progranulin deficient frontotemporal dementia.
    Alquezar C; Esteras N; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):386-403. PubMed ID: 25624003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia.
    Alquezar C; Salado IG; de la Encarnación A; Pérez DI; Moreno F; Gil C; de Munain AL; Martínez A; Martín-Requero Á
    Mol Neurodegener; 2016 Apr; 11(1):36. PubMed ID: 27138926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.
    de la Encarnación A; Alquézar C; Martín-Requero Á
    Mol Neurobiol; 2016 Dec; 53(10):7107-7118. PubMed ID: 26676574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
    Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
    Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers.
    Alquézar C; Esteras N; de la Encarnación A; Alzualde A; Moreno F; López de Munain A; Martín-Requero A
    Neurobiol Aging; 2014 Apr; 35(4):886-98. PubMed ID: 24139281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration.
    Reich M; Simon MJ; Polke B; Paris I; Werner G; Schrader C; Spieth L; Davis SS; Robinson S; de Melo GL; Schlaphoff L; Buschmann K; Berghoff S; Logan T; Nuscher B; de Weerd L; Edbauer D; Simons M; Suh JH; Sandmann T; Kariolis MS; DeVos SL; Lewcock JW; Paquet D; Capell A; Di Paolo G; Haass C
    Sci Transl Med; 2024 Jun; 16(750):eadj7308. PubMed ID: 38838131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.
    Mao Q; Zheng X; Gefen T; Rogalski E; Spencer CL; Rademakers R; Fought AJ; Kohler M; Weintraub S; Xia H; Mesulam MM; Bigio EH
    J Neuropathol Exp Neurol; 2019 Sep; 78(9):844-853. PubMed ID: 31361008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.
    Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB
    Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin Levels Decrease in Fibroblasts With Progranulin (PGRN) Pathogenic Variants and in a Cellular Model of PGRN Deficiency.
    Gaweda-Walerych K; Walerych D; Berdyński M; Buratti E; Zekanowski C
    Front Mol Neurosci; 2021; 14():676478. PubMed ID: 34054428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration.
    Zhu J; Wang N; Li X; Zheng X; Zhao J; Xia H; Mao Q
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1124-1129. PubMed ID: 31626287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.
    Alquezar C; Esteras N; Alzualde A; Moreno F; Ayuso MS; López de Munain A; Martín-Requero Á
    PLoS One; 2012; 7(5):e37057. PubMed ID: 22623979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination.
    Zhang T; Feng T; Wu K; Guo J; Nana AL; Yang G; Seeley WW; Hu F
    Acta Neuropathol; 2023 Jul; 146(1):97-119. PubMed ID: 37120788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.
    Bhopatkar AA; Uversky VN; Rangachari V
    J Biol Chem; 2020 Feb; 295(8):2506-2519. PubMed ID: 31911437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progranulin axis and recent developments in frontotemporal lobar degeneration.
    Nicholson AM; Gass J; Petrucelli L; Rademakers R
    Alzheimers Res Ther; 2012 Jan; 4(1):4. PubMed ID: 22277331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration.
    Mohan S; Sampognaro PJ; Argouarch AR; Maynard JC; Welch M; Patwardhan A; Courtney EC; Zhang J; Mason A; Li KH; Huang EJ; Seeley WW; Miller BL; Burlingame A; Jacobson MP; Kao AW
    Mol Neurodegener; 2021 Aug; 16(1):51. PubMed ID: 34344440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
    Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
    J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS.
    Chitramuthu BP; Kay DG; Bateman A; Bennett HP
    PLoS One; 2017; 12(3):e0174784. PubMed ID: 28358904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.